Friday, October 23, 2026
BTC $81,816 ▲ 0.62%
Subscribe
Menu
NewsLive WirePoliticsWorldMarketsDigital AssetsTechnologySports
FranchisesThe BriefThe Big ReadThe BreakdownCrypto Culture
MoreDeFi & On-ChainU.S. EquitiesMacro & RatesResearch
LIVE
ADA$0.217up+2.54%ETH$2,409up+0.93%LINK$12.04up+0.79%SOL$104.84up+1.26%BTC$81,816up+0.62%XRP$1.32up+1.00%S&P 5007,633down−0.40%Nasdaq26,014up+0.02%Dow52,269down−1.13%RUT2,763down−0.77%TNX4.99%up+0.75%TYX5.31%up+0.45%FVX4.81%up+0.88%IRX4.04%up+0.52%VIX20.18up+6.04%GOLD$4,038.90down−0.53%SILVER$54.10down−1.66%OIL$102.41up+2.96%DXY101.71up+0.10%NVDA$213.08up+0.41%AAPL$347.52down−0.20%TSLA$368.89down−1.52%META$645.80down−0.47%MSFT$521.38up+0.06%AMZN$249.12down−0.50%GOOGL$323.92down−0.09%Fear & Greed50 — NeutralADA$0.217up+2.54%ETH$2,409up+0.93%LINK$12.04up+0.79%SOL$104.84up+1.26%BTC$81,816up+0.62%XRP$1.32up+1.00%S&P 5007,633down−0.40%Nasdaq26,014up+0.02%Dow52,269down−1.13%RUT2,763down−0.77%TNX4.99%up+0.75%TYX5.31%up+0.45%FVX4.81%up+0.88%IRX4.04%up+0.52%VIX20.18up+6.04%GOLD$4,038.90down−0.53%SILVER$54.10down−1.66%OIL$102.41up+2.96%DXY101.71up+0.10%NVDA$213.08up+0.41%AAPL$347.52down−0.20%TSLA$368.89down−1.52%META$645.80down−0.47%MSFT$521.38up+0.06%AMZN$249.12down−0.50%GOOGL$323.92down−0.09%Fear & Greed50 — Neutral
Tag

dominion energy

1 article

Regeneron Rises 3.4% on Eye Drug Trial Win; Mobileye Gains on $1.5B Auto Deal
U.S. Equities157d ago
Regeneron Rises 3.4% on Eye Drug Trial Win; Mobileye Gains on $1.5B Auto Deal
Regeneron's geographic atrophy treatment met primary endpoint in Phase 3 trial while Mobileye landed multi-year European automaker contract